Skip to main content

Table 1 Patient demographics

From: Impact of azithromycin mass drug administration on the antibiotic-resistant gut microbiome in children: a randomized, controlled trial

Variable

Baseline

24-month follow-up

Placebo (n = 30)

Azithromycin (n = 30)

Placebo (n = 61)

Azithromycin (n = 61)

Median age in years (range)

2.87 (0.74–4.59)

2.88 (0.81–4.91)

2.45 (0.22–5.01)

2.17 (0.29–4.98)

Female (%)

16 (53.33)

12 (40.00)

27 (44.26)

30 (49.18)

Back to article page

Gut Pathogens

ISSN: 1757-4749